한일과학산업

비상장계속사업자

Hanil Scientific Inc

김선기,김용주

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

한일과학산업

Business Reg. No. 1228125620 · CEO 김선기,김용주

I.Investment Overview

Target한일과학산업 (1228125620)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명한일과학산업
영문명Hanil Scientific Inc
대표자김선기,김용주
사업자등록번호1228125620
법인등록번호1201110082529
설립일1993.03.01
종업원수50명

V.Workforce

50

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW118.52021136.12022122.32023101.82024110.32025
영업이익100M KRW19.4202123.720223.420236.6202416.42025
순이익100M KRW19.8202122.620222.620236.920245.32025
Item20252024202320222021
자산총계232.7억원217.3억원159.9억원162.1억원135.9억원
부채총계98.8억원88.7억원54.1억원58.9억원55.3억원
자본총계133.8억원128.6억원105.8억원103.2억원80.6억원
매출액110.3억원101.8억원122.3억원136.1억원118.5억원
영업이익16.4억원6.6억원3.4억원23.7억원19.4억원
순이익5.3억원6.9억원2.6억원22.6억원19.8억원

VII.Financial Ratios

FY2025 basis

14.85%

영업이익률

4.76%

순이익률

2.26%

ROA

3.92%

ROE

73.83%

부채비율

57.53%

자기자본비율

VIII.R&D Activity

Keywords 바이오오일, 초임계유체, 바이오촉매

YearProjectsPapersPatents
2011032
2010201

IX.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

한일과학산업 투심보고서 | Alpha Lenz